Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Melodiol Global Health.
RELATED STOCKHEAD STORIES
Health & Biotech
Melodiol unaudited revenue up 79% in Q1 FY24
Health & Biotech
Melodiol welcomes Chuck’s petition to pass US SAFER Banking Act
News
ASX Small Caps and IPO Weekly Wrap: A short week for a small win on the ASX
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: ASX too timid on Tuesday. Although Dart Mining has a decent Mesoblast
Health & Biotech
Melodiol’s Mernova gains more traction in Canada: revenues increase, new products launched
News
Top 10 at 10: Pot stock powers to profit, power company pulls M&A payday
News
Closing Bell: ASX rebounds as soft CPI bolsters August rate cut hopes; OSX and TLM lead today’s winners
Health & Biotech
Melodiol subsidiaries contribute $3.1 million revenue in first two months of 2024
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Local markets ride commodities higher after a blow to US confidence on Friday
Health & Biotech
Melodiol subsidiary Mernova expands products in six lucrative Canadian provinces
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
Melodiol subsidiaries deliver $2 million revenue to group in strong start to year
News
In Case You Missed It: Gold, uranium and a sudden leadership spill are driving the news today
News
ASX Small Caps Lunch Wrap: Who’s glad they didn’t spring for more leg room on their flight today?
News
